对癌症患者再辐射的跨学科方法
Shweta B Dahake1, Ashish Uke2, Anurag Luharia3
1Medical Physics, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|August 30, 2024
概括
再辐射 (re-RT) 越来越多地用于复发性瘤. 本综述探讨了决策因素,跨学科的护理,以及安全剂量的re-RT,旨在规范实践.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
背景情况:
- 系统疗法和放射性瘤学正在发展,导致复发性瘤更多的再辐射 (re-RT).
- 重新治疗的决策涉及复杂的因素,包括以前的治疗细节,复发性质和疾病程度.
研究的目的:
- 审查当前的决策实践,以重新开发技术.
- 探索对重复治疗患者的跨学科关注.
- 根据放射生物学和以前的RT,定义可接受的风险器官 (OAR) 剂量.
主要方法:
- 对重新技术技术的决策流程的审查.
- 分析跨学科的护理模式.
- 对OAR剂量限制的放射生物学原理的评估.
主要成果:
- 在全球范围内的re-RT决策工作流程中存在异质性.
- 了解以前的RT和瘤放射生物学对于安全的重新RT至关重要.
- 证据表明,在重新RT执行方面,有了改进的技术.
结论:
- 需要标准化再技术决策和跨学科的护理.
- 优化OAR剂量需要对放射生物学和先前治疗有深入的了解.
- 对有效的重复治疗技术的进一步研究可以改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


